Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Heart Failure Clinical Trials

A listing of Heart Failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (59) clinical trials

This is an event-driven Phase IIIb, multicentre, randomised, clinical study to demonstrate the efficacy of AdreView™ imaging for appropriately guiding the decision of implantable cardioverter defibrillator (ICD) implantation, in New York Health Association (NYHA) class II and III heart failure patients with 30%=left ventricular ejection fraction (LVEF)=35%%, and in particular, ...

Phase

The primary objective of this study is to assess the effect of oral treprostinil compared with placebo on change in exercise capacity as measured by change in 6MWD from Baseline to Week 24 in subjects with PH associated with HFpEF. There are no approved treatments for PH in subjects with ...

Phase

The objective of this event-driven trial is to demonstrate superiority of empagliflozin 10 mg versus placebo in patients with symptomatic, chronic HF and preserved ejection fraction (LVEF > 40%) under stable treatment of HF symptoms. The trial will be performed in patients with chronic heart failure with an ejection fraction ...

Phase

The objective of this event-driven trial is to demonstrate superiority of empagliflozin 10 mg versus placebo on top of guideline-directed medical therapy in patients with symptomatic, chronic HF and reduced ejection fraction (LVEF ≤ 40%). Patients with chronic HF diagnosed for at least 3 months before Visit 1.

Phase

The purpose of this study is to see if starting sacubitril/valsartan (Entresto) while in the hospital, as compared to Enalapril, will have an effect on the blood test called NT-proBNP, that reflects elevated pressures or stress on the heart, in patients that have been hospitalized for a type of heart ...

Phase

The purpose of this study is to investigate if rivaroxaban in combination with standard care (the other medications you are currently taking for your heart failure (HF) and coronary artery disease (CAD)) can reduce the risk of a heart attack, stroke or death in patients with Chronic Heart Failure and ...

Phase

To evaluate the safety and efficacy of a once daily oral medication compared to a placebo, in patients with chronic Heart Failure with preserved Ejection Fraction.

Phase

Don't wait, participate! A clinical trial for heart failure is now enrolling. Play an active role in your health care and contact us to see if you qualify to participate in this trial.

Phase

Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency

This is a double-blind, multicenter, prospective, randomized, placebo-controlled study to assess the effects of IV FCM compared to placebo on the 12-month rate of death, hospitalization for worsening heart failure, and the 6-month change in 6 minute walk test (6MWT) for patients in heart failure with iron deficiency. After an ...

Phase